These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24694799)

  • 21. Prognostic value of serial electrocardiographic voltage and repolarization changes in essential hypertension: the HEART Survey study.
    Verdecchia P; Reboldi G; Angeli F; Avanzini F; de Simone G; Pede S; Perticone F; Schillaci G; Vanuzzo D; Maggioni AP;
    Am J Hypertens; 2007 Sep; 20(9):997-1004. PubMed ID: 17765142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy.
    Gerdts E; Okin PM; Boman K; Wachtell K; Nieminen MS; Dahlöf B; Devereux RB
    Am J Hypertens; 2012 Jun; 25(6):678-83. PubMed ID: 22456225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM
    J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension.
    Pierdomenico SD; Lapenna D; Cuccurullo F
    Am J Hypertens; 2008 Apr; 21(4):464-70. PubMed ID: 18369364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between electrocardiographic left ventricular hypertrophy with strain pattern and left ventricular structure and function.
    Ogah OS; Adebiyi AA; Oladapo OO; Aje A; Ojji DB; Adebayo AK; Salako BL; Falase AO
    Cardiology; 2006; 106(1):14-21. PubMed ID: 16601328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left ventricular hypertrophy and microalbuminuria in patients with essential hypertension.
    Monfared A; Salari A; Mirbolok F; Momeni M; Shafighnia S; Shakiba M; Sheikholeslami A
    Iran J Kidney Dis; 2013 May; 7(3):192-7. PubMed ID: 23689150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
    Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
    G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men.
    Sundström J; Lind L; Arnlöv J; Zethelius B; Andrén B; Lithell HO
    Circulation; 2001 May; 103(19):2346-51. PubMed ID: 11352882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of left ventricular hypertrophy as assessed by electrocardiogram in treated hypertensive persons in general practice.
    van den Hoogen JP; van Kruijsdijk MC; van Ree JW; Mokkink HG; Thien T; van Weel C
    J Hum Hypertens; 1993 Oct; 7(5):473-7. PubMed ID: 8263888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender differences in factors influencing electrocardiographic findings of left ventricular hypertrophy in severe aortic stenosis.
    Satoh S; Omura S; Inoue H; Ejima E; Shimozono K; Hayashi M; Mori T; Takenaka K; Kawamura N; Numaguchi K; Mori E; Asoh A; Nakamura T; Hiyamuta K
    Heart Vessels; 2014 Sep; 29(5):659-66. PubMed ID: 23979264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Value of Electrocardiographic Left Ventricular Hypertrophy on Cardiovascular Risk in a Non-Hypertensive Community-Based Population.
    Tanaka K; Tanaka F; Onoda T; Tanno K; Ohsawa M; Sakata K; Omama S; Ogasawara K; Ishibashi Y; Itai K; Kuribayashi T; Okayama A; Nakamura M;
    Am J Hypertens; 2018 Jul; 31(8):895-901. PubMed ID: 29659657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical importance of detecting exaggerated blood pressure response to exercise on antihypertensive therapy.
    Mizuno R; Fujimoto S; Saito Y; Yamazaki M
    Heart; 2016 Jun; 102(11):849-54. PubMed ID: 26839069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Wedel H; Lindholm LH; Dahlöf B;
    JAMA; 2004 Nov; 292(19):2343-9. PubMed ID: 15547161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrocardiographic left ventricular hypertrophy predicts atrial fibrillation independent of left ventricular mass.
    Patel N; O'Neal WT; Whalen SP; Soliman EZ
    Ann Noninvasive Electrocardiol; 2017 May; 22(3):1-5. PubMed ID: 28019050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of Electrocardiographic Left Ventricular Hypertrophy and Resting Heart Rate Over Time: Findings From the OGHMA Study.
    Inoue T; Arima H; Katsuimata Y; Iseki C; Kinjo K; Iseki K
    Angiology; 2020 Jan; 71(1):70-76. PubMed ID: 31446774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of African Ancestry With Electrocardiographic Voltage and Concentric Left Ventricular Hypertrophy: The Dallas Heart Study.
    Alame AJ; Garg S; Kozlitina J; Ayers C; Peshock RM; Matulevicius SA; Drazner MH
    JAMA Cardiol; 2018 Dec; 3(12):1167-1173. PubMed ID: 30427995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus: Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial.
    Soliman EZ; Byington RP; Bigger JT; Evans G; Okin PM; Goff DC; Chen H
    Hypertension; 2015 Dec; 66(6):1123-9. PubMed ID: 26459421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN; Devereux RB; Okin PM
    J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of discrepancies in detection and comparison of the prognostic significance of left ventricular hypertrophy by electrocardiogram and cardiac magnetic resonance imaging.
    Bacharova L; Chen H; Estes EH; Mateasik A; Bluemke DA; Lima JA; Burke GL; Soliman EZ
    Am J Cardiol; 2015 Feb; 115(4):515-22. PubMed ID: 25542394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum uric acid level and left ventricular hypertrophy in elderly male patients with nonvalvular atrial fibrillation.
    Liang WY; Liu WW; Liu ML; Xiang W; Feng XR; Huang B; Chen XH; Sun YS
    Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):575-580. PubMed ID: 27162100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.